TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/26/23 16:34 | 6/23/23 | DMAC | Diamedica Therapeutics Inc. | Z4 | Health | Drug | Pharmaceutical Preparations | Pauls Dietrich John | MN | DO | P,CEO | P | 50 | 3.91 | 0 | 13 | 23 | 69 | D | ||||||||||||||
11/16/22 20:56 | 11/16/22 | DMAX | Diamedica Therapeutics Inc. | Z4 | Health | Drug | Pharmaceutical Preparations | Pauls Dietrich John | MN | DO | P,CEO | P | 24 | 1.21 | 0 | 20 | 56 | 56 | D | ||||||||||||||
8/16/21 16:19 | 8/16/21 | DMAC | Diamedica Therapeutics Inc. | Z4 | Health | Drug | Pharmaceutical Preparations | Pauls Dietrich John | MN | DO | P,CEO | P | 16 | 3.14 | 0 | 5 | 16 | 36 | D | ||||||||||||||
8/16/19 16:31 | 8/16/19 | DMAC | Diamedica Therapeutics Inc. | Z4 | Health | Drug | Pharmaceutical Preparations | Pauls Dietrich John | MN | DO | P,CEO | P | 3 | 2.68 | 0 | 1 | 3 | 31 | D | ||||||||||||||
12/11/18 16:31 | 12/11/18 | DMAC | Diamedica Therapeutics Inc. | Z4 | Health | Drug | Pharmaceutical Preparations | Pauls Dietrich John | MN | DO | P,CEO | P | 20 | 4.00 | 0 | 5 | 20 | 30 | D |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |